Zevra Therapeutics to Participate at Upcoming Investor Events
Zevra Therapeutics, Inc. (ZVRA)
Company Research
Source: GlobeNewswire
CELEBRATION, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane, President and Chief Executive Officer of Zevra, will present at several upcoming investor events in May 2024. Additionally, management will be available for one-on-one meetings with registered attendees. Mr. McFarlane will present at The Citizens JMP Life Sciences Conference in New York, NY, on Tuesday, May 14, at 1 p.m. ET. Mr. McFarlane will present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at the NASDAQ World Headquarters in New York, NY, on Monday, May 20, at 9:30 a.m. ET. Mr. McFarlane and members of the Zevra management team will also attend and be available for one-on-one meetings at the Mizuho Neurosciences Summit in Boston, MA, on May 21. Live webcasts can be accessed through the “Events & Presentations” section of Zevra’s website at investors.zevra.com. A
Show less
Read more
Impact Snapshot
Event Time:
ZVRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZVRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZVRA alerts
High impacting Zevra Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ZVRA
News
- Anumana Appoints Harry S. Palmin as CFO [Yahoo! Finance]Yahoo! Finance
- Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRAAccesswire
- Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate UpdatesGlobeNewswire
ZVRA
Earnings
- 5/8/24 - Beat
ZVRA
Sec Filings
- 5/15/24 - Form 4
- 5/15/24 - Form 4
- 5/15/24 - Form 4
- ZVRA's page on the SEC website